These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31530011)

  • 1. IDH2 reprograms mitochondrial dynamics in cancer through a HIF-1α
    Wang Y; Agarwal E; Bertolini I; Ghosh JC; Seo JH; Altieri DC
    FASEB J; 2019 Dec; 33(12):13398-13411. PubMed ID: 31530011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mtDNA as a Mediator for Expression of Hypoxia-Inducible Factor 1α and ROS in Hypoxic Neuroblastoma Cells.
    Kuo CW; Tsai MH; Lin TK; Tiao MM; Wang PW; Chuang JH; Chen SD; Liou CW
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.
    Li JJ; Yu T; Zeng P; Tian J; Liu P; Qiao S; Wen S; Hu Y; Liu Q; Lu W; Zhang H; Huang P
    Nat Commun; 2024 Apr; 15(1):3445. PubMed ID: 38658533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.
    Archer SL; Gomberg-Maitland M; Maitland ML; Rich S; Garcia JG; Weir EK
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H570-8. PubMed ID: 18083891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation.
    Yang JX; Chuang YC; Tseng JC; Liu YL; Lai CY; Lee AY; Huang CF; Hong YR; Chuang TH
    J Exp Clin Cancer Res; 2024 Jun; 43(1):169. PubMed ID: 38880883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of tumorigenesis in mitochondrial NADP(+)-dependent isocitrate dehydrogenase knock-out mice.
    Kim S; Kim SY; Ku HJ; Jeon YH; Lee HW; Lee J; Kwon TK; Park KM; Park JW
    Biochim Biophys Acta; 2014 Feb; 1842(2):135-43. PubMed ID: 24240089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production.
    Bell EL; Emerling BM; Ricoult SJ; Guarente L
    Oncogene; 2011 Jun; 30(26):2986-96. PubMed ID: 21358671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-electron transfer chain mitochondrial defects differently regulate HIF-1α degradation and transcription.
    Shvetsova AN; Mennerich D; Kerätär JM; Hiltunen JK; Kietzmann T
    Redox Biol; 2017 Aug; 12():1052-1061. PubMed ID: 28531964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial bioenergetics of metastatic breast cancer cells in response to dynamic changes in oxygen tension: effects of HIF-1α.
    Diers AR; Vayalil PK; Oliva CR; Griguer CE; Darley-Usmar V; Hurst DR; Welch DR; Landar A
    PLoS One; 2013; 8(6):e68348. PubMed ID: 23840849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions.
    Calgani A; Delle Monache S; Cesare P; Vicentini C; Bologna M; Angelucci A
    Cancer Lett; 2016 Jun; 376(1):1-9. PubMed ID: 26996298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming.
    Jin J; Qiu S; Wang P; Liang X; Huang F; Wu H; Zhang B; Zhang W; Tian X; Xu R; Shi H; Wu X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):377. PubMed ID: 31455352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications.
    Sun W; Wang B; Qu XL; Zheng BQ; Huang WD; Sun ZW; Wang CM; Chen Y
    Cells; 2019 Dec; 9(1):. PubMed ID: 31905813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of hypoxia-inducible factor-1α expression by mitochondrial NADP+-dependent isocitrate dehydrogenase.
    Kim SY; Park JW
    Biochimie; 2010 Dec; 92(12):1908-13. PubMed ID: 20713124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductive carboxylation supports redox homeostasis during anchorage-independent growth.
    Jiang L; Shestov AA; Swain P; Yang C; Parker SJ; Wang QA; Terada LS; Adams ND; McCabe MT; Pietrak B; Schmidt S; Metallo CM; Dranka BP; Schwartz B; DeBerardinis RJ
    Nature; 2016 Apr; 532(7598):255-8. PubMed ID: 27049945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer.
    Gu J; Li Y; Zeng J; Wang B; Ji K; Tang Y; Sun Q
    Sci Rep; 2017 Aug; 7(1):7546. PubMed ID: 28790395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in isocitrate dehydrogenase 2 accelerate glioma cell migration via matrix metalloproteinase-2 and 9.
    Fu Y; Zheng Y; Li K; Huang R; Zheng S; An N; Liang A
    Biotechnol Lett; 2012 Mar; 34(3):441-6. PubMed ID: 22105553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated mitochondrial reactive oxygen species generation affects the immune response via hypoxia-inducible factor-1alpha in long-lived Mclk1+/- mouse mutants.
    Wang D; Malo D; Hekimi S
    J Immunol; 2010 Jan; 184(2):582-90. PubMed ID: 20007531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia Promotes Mitochondrial Complex I Abundance via HIF-1α in Complex III and Complex IV Eficient Cells.
    Saldana-Caboverde A; Nissanka N; Garcia S; Lombès A; Diaz F
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.